Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Obesity is associated with activated and insulin resistant immune cells.

Viardot A, Heilbronn LK, Samocha-Bonet D, Mackay F, Campbell LV, Samaras K.

Diabetes Metab Res Rev. 2012 Jul;28(5):447-54. doi: 10.1002/dmrr.2302. Epub 2012 Apr 10.

PMID:
22492715
2.

Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.

Zeyda M, Huber J, Prager G, Stulnig TM.

Obesity (Silver Spring). 2011 Apr;19(4):743-8. doi: 10.1038/oby.2010.123. Epub 2010 May 27.

3.

T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.

McLaughlin T, Liu LF, Lamendola C, Shen L, Morton J, Rivas H, Winer D, Tolentino L, Choi O, Zhang H, Hui Yen Chng M, Engleman E.

Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2637-43. doi: 10.1161/ATVBAHA.114.304636. Epub 2014 Oct 23.

4.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

5.

Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects.

Graziani F, Cialdella P, Liuzzo G, Basile E, Brugaletta S, Pedicino D, Leccesi L, Guidone C, Iaconelli A, Mingrone G, Biasucci LM, Crea F.

Eur J Intern Med. 2011 Aug;22(4):418-23. doi: 10.1016/j.ejim.2011.04.010. Epub 2011 May 26.

PMID:
21767762
6.

[The effect of body weight on insulin activity].

Sindelka G, Skrha J, Prázný M, Hilgertová J.

Vnitr Lek. 1999 Sep;45(9):540-4. Czech.

PMID:
10951879
7.

Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue.

Harford KA, Reynolds CM, McGillicuddy FC, Roche HM.

Proc Nutr Soc. 2011 Nov;70(4):408-17. doi: 10.1017/S0029665111000565. Epub 2011 Aug 12. Review.

PMID:
21835098
8.

The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes.

Viardot A, Lord RV, Samaras K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2845-50. doi: 10.1210/jc.2009-2371. Epub 2010 Apr 7.

PMID:
20375213
9.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
10.

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G.

Int J Obes (Lond). 2005 Jul;29(7):766-71.

PMID:
15917853
11.

[Expression of omentin in adipose tissues in obese and type 2 diabetic patients].

Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Feb 17;89(6):381-4. Chinese.

PMID:
19567114
12.

Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance.

Samaras K, Viardot A, Lee PN, Jenkins A, Botelho NK, Bakopanos A, Lord RV, Hayward CS.

Diab Vasc Dis Res. 2013 Jan;10(1):40-8. doi: 10.1177/1479164112443375. Epub 2012 Apr 25.

PMID:
22535587
13.

Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production.

Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Györi G, Zlabinger GJ, Stulnig TM.

Int J Obes (Lond). 2007 Sep;31(9):1420-8. Epub 2007 Jun 26.

PMID:
17593905
15.

Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro.

Chacón MR, Miranda M, Jensen CH, Fernández-Real JM, Vilarrasa N, Gutiérrez C, Näf S, Gomez JM, Vendrell J.

Int J Obes (Lond). 2008 Jul;32(7):1122-9. doi: 10.1038/ijo.2008.40. Epub 2008 Apr 8.

PMID:
18392037
16.

Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery.

Murri M, García-Fuentes E, García-Almeida JM, Garrido-Sánchez L, Mayas MD, Bernal R, Tinahones FJ.

Obes Surg. 2010 Mar;20(3):363-8. doi: 10.1007/s11695-009-0021-6.

PMID:
20217956
17.

Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity.

Cottam DR, Schaefer PA, Shaftan GW, Velcu L, Angus LD.

Obes Surg. 2002 Jun;12(3):335-42.

PMID:
12082883
18.

Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.

Makkonen J, Westerbacka J, Kolak M, Sutinen J, Cornér A, Hamsten A, Fisher RM, Yki-Järvinen H.

Int J Obes (Lond). 2007 Oct;31(10):1617-25. Epub 2007 Apr 24.

PMID:
17452990
19.

Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.

Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS.

N Engl J Med. 2004 Jun 17;350(25):2549-57.

20.

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

Heilbronn LK, Campbell LV.

Curr Pharm Des. 2008;14(12):1225-30. Review.

PMID:
18473870

Supplemental Content

Support Center